Topic: Gsk

The discussion covers the FDA's approval of a new RSV vaccine produced by GSK. Dr. Ruby claims the "RSV pandemic" predicted by the National Foundation of Infectious Disease never materialized and that the symptoms are identical to the common cold. She argues that the PCR test is being misused to diagnose RSV and scare the public into taking more injections.

A caller named Jordan, claiming to be a former R&D worker for Pfizer and GSK, discusses how NIH grant funding is becoming harder to trace. The conversation focuses on the implementation of Central Bank Digital Currencies (CBDCs) as a method for monitoring physiological activity and enforcing a social credit score. The goal is described as a total integration of technology and financial control.